The use of reflex high-risk human papillomavirus testing for atypical squamous cells of undetermined significance interpretations on vaginal specimens

Cancer Cytopathology

Volumn 117, Issue 1, 2009, Pages 27-31

  Kendall, Brian S ^a   Zahn, Christopher M ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Atypical squamous cells of undetermined significance; Cytology; High risk human papillomavirus; Vaginal smears

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; EPITHELIUM; FEMALE; HUMAN; HYSTERECTOMY; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; VAGINA SMEAR; VAGINA TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VAGINAL NEOPLASMS; VAGINAL SMEARS;

EID: 65349083248     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20012     Document Type: Article

References (14)

1. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests [see comment]. Am J Obstet Gynecol. 2007;197:346-355.
2. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology [see comment]. JAMA. 2002;287:2114-2119.
3. Pearce KF, Haefner HK, Sarwar SF, Nolan TE. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med. 1996;335:1559-1562.
4. Fox J, Remington P, Layde P, Klein G. The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result. Am J Obstet Gynecol. 1999;180:1104-1109.
5. Miller AB, Visentin T, Howe GR. The effect of hysterectomies and screening on mortality from cancer of the uterus in Canada. Int J Cancer. 1981;27:651-657.
6. Eaker EDS, Vierkant RAM, Konitzer KA, Remington PLM. Cervical cancer screening among women with and without hysterectomies. Obstet Gynecol. 1998;91:551-555.
7. American College of Obstetricians and Gynecologists. Cervical Cytology Screening. ACOG Practice Bulletin Number 45. Washington, DC: American College of Obstetricians and Gynecologists; 2003.
8. US Preventive Services Task Force (USPSTF). Screening for Cervical Cancer: Recommendations and Rationale. Released January 2003. Available at: http://www/ahrq.gov/clinic/uspstf/uspscerv.htm 2003 Accessed on April 14, 2008.
9. Guidelines for the Early Detection of Cancer. Available at: http://www.cancer.org/docroot/PED/content/PED-2-3X-ACS-Cancer-Detection- Guidelines-36.asp. Accessed on April 14, 2008.
10. Solomon D, Schiffman M, Tarone R, Group AS. Comparison of 3 management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
11. Kendall BS, Bush AC, Olsen CH, Zahn CM. Reflex highrisk human papillomavirus testing for women with atypical squamous cells of undetermined significance in cytologic smears: effects since implementation in a large clinical practice. Am J Clin Pathol. 2005;123:524-528.
12. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281:1605-1610.
13. Ferris DG, Wright TC Jr, Litaker MS, et al. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy [see comment]? J Fam Pract. 1998;46:125-134.
14. Wright TC Jr, Lorincz A, Ferris DG, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol. 1998;178:962-966.